Quarterly report pursuant to Section 13 or 15(d)

9. Supplemental Disclosure of Cash Flow Information

v3.5.0.2
9. Supplemental Disclosure of Cash Flow Information
 6 Months Ended
Jun. 30, 2016
Supplemental Cash Flow Elements [Abstract]  
Supplemental Disclosure of Cash Flow Information

  Six Months Ended June 30,  
    2016     2015  
Cash paid for interest   $ 858,741     $ 136,028  
Cash paid for income taxes   $ –     $ 570,831  
                 
Non-cash investing and financing activities:                
Exercise of stock options as reduction of notes payable, related party   $ –     $ (2,500,000 )
Assets acquired through capital leases   $ –     $ 1,046,126  
Acquisition of noncontrolling interest in Biohealth Medical Laboratory, Inc.:                
Deposits on acquisition   $ –     $ 259,875  
Goodwill   $ –     $ (138,871 )
Noncontrolling interest   $ –     $ (121,004 )